Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses

Journal of Investigative Dermatology

Volumn 127, Issue 8, 2007, Pages 1883-1885

  Hafner, Christian ^a   Hartmann, Arndt ^a   Real, Francisco X ^b   Hofstaedter, Ferdinand ^a   Landthaler, Michael ^a   Vogt, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; HUMAN; INDIVIDUALITY; MAJOR CLINICAL STUDY; MUTATION RATE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; SEBORRHEIC KERATOSIS;

HUMANS; KERATOSIS, SEBORRHEIC; MUTATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 34447556773     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700804     Document Type: Article

References (15)

1. Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X et al. (1999) Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet 23:18-20
2. Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139-49
3. Hafner C, van Oers JM, Hartmann A, Landthaler M, Stoehr R, Blaszyk H et al. (2006a) High frequency of FGFR3 mutations in adenoid seborrheic keratoses. J Invest Dermatol 126:2404-7
4. Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H et al. (2006b) Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 116:2201-7
5. Hafner C, Vogt T, Hartmann A (2006c) FGFR3 mutations in benign skin tumors. Cell Cycle 5:2723-8
6. Kwon OS, Hwang EJ, Bae JH, Park HE, Lee JC, Youn JI et al. (2003) Seborrheic keratosis in the Korean males: causative role of sunlight. Photodermatol Photoimmunol Photomed 19:73-80
7. Lasky T, Magder L (1997) Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure? Environ Health Perspect 105:392-7
8. L'Hote CG, Knowles MA (2005) Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 304:417-31
9. Logie A, Dunois-Larde C, Rosty C, Levrel O, Blanche M, Ribeiro A et al. (2005) Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 14:1153-60
10. Lopez-Knowles E, Hernandez S, Malats N, Kogevinas M, Lloreta J, Carrato A et al. (2006) PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res 66:7401-4
11. Naski MC, Wang Q, Xu J, Ornitz DM (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 13:233-7
12. Vajo Z, Francomano CA, Wilkin DJ (2000) The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 21:23-39
13. van Oers JM, Lurkin I, van Exsel AJ, Nijsen Y, van Rhijn BW, van der Aa MN et al. (2005) A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine. Clin Cancer Res 11:7743-8
14. Wilkie AO (1997) Craniosynostosis: genes and mechanisms. Hum Mol Genet 6:1647-56
15. Yeatman JM, Kilkenny M, Marks R (1997) The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol 137:411-4